CRSP News and Press, CRISPR Therapeutics AG From 02/18/26

2026-02-18 23:42:25 ET Investment Thesis GARP (Growth At a Reasonable Price) is by far my preferred strategy, strictly speaking about stocks, because options are much more complex and versatile. And while my stock portfolio is mostly focused on IT (hardware and software), I also loo...

2026-02-18 14:14:57 ET CRISPR Therapeutics AG (CRSP) Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 10:45 AM EST... Read the full article on Seeking Alpha For further details see: CRISPR Therapeutics AG (CRSP) Presents at Citi's 2026 Virtual Oncology Leader...

2026-02-18 13:44:55 ET Since my last article in September, " Vertex Pharmaceuticals: Trikafta And Alyftrek Cement Market Leadership ," Vertex Pharmaceuticals Incorporated ( VRTX ) stock is up 25.1%.... Read the full article on Seeking Alpha For further detail...

2026-02-18 10:13:00 ET Investors have bought into the promise of CRISPR technology for years. The ability to target and edit genes to treat cancer and various genetic conditions is an obvious home run. CRISPR Therapeutics (NASDAQ: CRSP) won the race to market, partnering with Vert...

2026-02-17 14:30:38 ET Overview I’ve covered CRISPR Therapeutics ( CRSP ) for quite a while now. Until just recently, my focus has predominantly been on its ex vivo sickle cell disease gene therapy product, CASGEVY, which it co-markets with Vertex Pharmaceuticals ( VRTX...

2026-02-17 11:49:09 ET CRISPR Therapeutics AG ( CRSP ), which has traded approximately flat since my last analysis of the company, has entered 2026 with strong proof of concept. Fiscal 2025 has demonstrated early-stage commercial traction, but the company's financials undoubtedl...

2026-02-16 07:40:00 ET Cathie Wood’s ARK Invest ETFs continued a similar trend from the last week, rotating further into crypto-linked platforms, fintech, and gene-editing names while trimming exposure to software, digital advertising, and consumer internet names.... Read t...

2026-02-13 15:30:00 ET When you're looking to add growth to your portfolio, you may immediately think of technology stocks -- and this is a great idea. But technology stocks aren't the only players that may supercharge your portfolio. Another place to seek out potentially explosive stocks i...

2026-02-13 14:22:51 ET By all accounts its stock should be in the red today. CRISPR Therapeutics (NASDAQ: CRSP) only reported $864,000 in fourth-quarter revenue after Thursday's closing bell, leading to a loss of $1.37 per share versus analysts' estimates for a loss of only around $...

2026-02-13 09:35:07 ET More on The Health Care Select Sector SPDR® Fund ETF Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More CMS Rates Proposal Shatters Health Insurance Stocks: What Investors Must Know (& Do) Insurers Br...